当前位置:首页 - 行情中心 - 鹭燕医药(002788) - 财务分析 - 现金流量表

鹭燕医药

(002788)

  

流通市值:32.19亿  总市值:32.75亿
流通股本:3.82亿   总股本:3.89亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金11,373,235,408.135,493,673,487.9622,246,773,674.9916,773,182,605.57
  收到的税费返还1,389,764.96534,498.97524,096.61,937,751.84
  收到其他与经营活动有关的现金107,900,409.1593,217,704.581,353,163.11227,375,995.43
  经营活动现金流入小计11,482,525,582.245,587,425,691.4322,328,650,934.717,002,496,352.84
  购买商品、接受劳务支付的现金10,587,178,008.985,269,837,665.1620,556,909,627.7715,757,078,590.94
  支付给职工以及为职工支付的现金300,622,475.73160,828,026.67559,664,205.75427,648,935.85
  支付的各项税费205,399,123.6591,980,588.9385,405,994.85299,753,449.53
  支付其他与经营活动有关的现金178,607,983.8146,108,470.96249,187,652.79220,290,965.55
  经营活动现金流出小计11,271,807,592.165,668,754,751.6921,751,167,481.1616,704,771,941.87
  经营活动产生的现金流量净额210,717,990.08-81,329,060.26577,483,453.54297,724,410.97
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额751,552.3525,191.87442,908.19245,962.84
  投资活动现金流入小计751,552.3525,191.87442,908.19245,962.84
  购建固定资产、无形资产和其他长期资产支付的现金109,104,123.5964,271,105.09361,123,708.58274,931,480.19
  投资支付的现金2,092,5001,710,0008,895,0008,250,000
  取得子公司及其他营业单位支付的现金--149,337.59-
  支付其他与投资活动有关的现金---18,820,955
  投资活动现金流出小计111,196,623.5965,981,105.09370,168,046.17302,002,435.19
  投资活动产生的现金流量净额-110,445,071.24-65,955,913.22-369,725,137.98-301,756,472.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金618,000618,0001,450,0001,200,000
  其中:子公司吸收少数股东投资收到的现金618,000618,0001,450,0001,200,000
  取得借款收到的现金4,644,876,420.772,489,749,081.248,942,679,409.927,097,012,319.33
  收到其他与筹资活动有关的现金-3,400,000-1,939,105
  筹资活动现金流入小计4,645,494,420.772,493,767,081.248,944,129,409.927,100,151,424.33
  偿还债务支付的现金4,629,035,9842,350,940,130.38,859,874,787.396,906,541,425.44
  分配股利、利润或偿付利息支付的现金89,812,101.3445,239,322.58324,561,154.81260,669,260.71
  其中:子公司支付给少数股东的股利、利润--734,561.78734,561.78
  支付其他与筹资活动有关的现金35,532,807.9614,871,796.7188,249,551.4854,690,402.11
  筹资活动现金流出小计4,754,380,893.32,411,051,249.599,272,685,493.687,221,901,088.26
  筹资活动产生的现金流量净额-108,886,472.5382,715,831.65-328,556,083.76-121,749,663.93
四、汇率变动对现金及现金等价物的影响-187,961.55-32,045.53214,377.14-51,389.76
五、现金及现金等价物净增加额-8,801,515.24-64,601,187.36-120,583,391.06-125,833,115.07
  加:期初现金及现金等价物余额340,924,904.24340,924,904.24461,508,295.3461,508,295.3
  期末现金及现金等价物余额332,123,389276,323,716.88340,924,904.24335,675,180.23
补充资料:
  净利润153,439,626.26-347,697,966.5-
  资产减值准备8,162,480.48-2,687,427.41-
  固定资产和投资性房地产折旧33,994,619.3-63,545,278.67-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,994,619.3-63,545,278.67-
  无形资产摊销2,456,876.61-5,024,785.92-
  长期待摊费用摊销5,412,776.11-11,297,323.34-
  处置固定资产、无形资产和其他长期资产的损失-98,166.8--172,333.63-
  固定资产报废损失191,390.26-87,804.67-
  公允价值变动损失--0-
  财务费用94,698,322.68-207,634,120.38-
  投资损失9,374,070.99-18,730,952.34-
  递延所得税-2,915,996.13--9,665,685.8-
  其中:递延所得税资产减少-2,758,657.49--9,397,581.56-
    递延所得税负债增加-157,338.64--268,104.24-
  存货的减少294,881,254.12--292,389,396.11-
  经营性应收项目的减少-297,639,539.91--400,019,113.69-
  经营性应付项目的增加-121,928,689.66-560,472,106.54-
  其他--0-
  现金的期末余额332,123,389-340,924,904.24-
  减:现金的期初余额340,924,904.24-461,508,295.3-
  现金及现金等价物的净增加额-8,801,515.24--120,583,391.06-
公告日期2025-08-262025-04-222025-04-222024-10-22
审计意见(境内)标准无保留意见
TOP↑